“ (Weight loss medications) can help, for sure, but exercise and getting enough protein to make sure you aren’t losing muscle ...

SURPASS-2 was an open label, 40-week, phase-3 trial which randomized patients to receive once-weekly injections of Mounjaro at a dose of 5 mg, 10 mg, or 15 mg, or Ozempic at a dose of 1 mg.

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

Eli Lilly and Company (NYSE: LLY) today announced Zepbound® (tirzepatide) 2.5 mg and 5 mg single-dose vials ... safety of tirzepatide (Zepbound® and Mounjaro®) once weekly for long-term weight ...

Have you finally decided to explore treatment plans for weight loss or erectile dysfunction? Are you finding that ...

The latest weight loss medications, like Mounjaro, could be provided to help ... help manage blood sugar and are used to treat type 2 diabetes and obesity. Other GLP-1 agonists include semaglutide ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound were ... That all came to an end Oct. 2, when the FDA confirmed Eli Lilly’s ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...